Target intelligence / Profile preview

Pathogenic bacterial surface structures

Molecular classification
Other
01

Overview

Pathogenic bacterial surface structures represent a broad category of complex molecules and assemblies located on the exterior of bacterial cells, including the peptidoglycan cell wall, lipopolysaccharides (LPS), capsules, S-layers, pili, and flagella (Silhavy et al., 2010, Cold Spring Harbor Perspectives in Biology). These structures are essential for maintaining bacterial cell shape, protecting against osmotic pressure, and facilitating interactions with the host environment, such as adhesion and colonization (Auer & Weibel, 2017, Nature Reviews Microbiology). In the context of infection, these components often function as Pathogen-Associated Molecular Patterns (PAMPs) that are recognized by the host's innate immune system via Pattern Recognition Receptors (PRRs) (Mogensen, 2009, Clinical Microbiology Reviews). Because many of these structures are unique to bacteria and absent in human cells, they are ideal targets for therapeutic intervention. For instance, beta-lactam antibiotics and glycopeptides target the synthesis of the peptidoglycan layer, leading to bacterial lysis (Kohanski et al., 2010, Nature Reviews Microbiology). Furthermore, surface polysaccharides are the primary components of many highly effective vaccines, such as those against Streptococcus pneumoniae and Haemophilus influenzae type b, which induce protective antibody responses (Pollard et al., 2009, Nature Reviews Immunology). However, the clinical utility of targeting these structures is increasingly challenged by the emergence of antimicrobial resistance and the potential for systemic inflammatory responses, such as the Jarisch-Herxheimer reaction, following the rapid release of bacterial components like endotoxins (Bryceson, 1970, Journal of Infectious Diseases).

Other names
Bacterial cell wall componentsPathogen-associated molecular patternsPAMPsBacterial surface antigensBacterial envelopeBacterial cell surface
02

Mechanism of action

Inhibition of cell wall biosynthesis, disruption of membrane integrity, neutralization of surface antigens, and induction of opsonophagocytosis.

03

Biological functions

Immune responseOther
04

Disease associations

Infection
05

Safety considerations

Antimicrobial resistanceJarisch-Herxheimer reactionMicrobiome dysbiosisHypersensitivity reactions
06

Interacting drugs

Penicillin G

7 more in the full profile.

07

Biomarkers

ProcalcitoninC-reactive proteinBacterial DNABacterial surface antigens

Beyond the preview

Go deeper on Pathogenic bacterial surface structures.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pathogenic bacterial surface structures.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call